Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteria (Q36670352)

15 August 2017

Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteria (English)

1 reference

15 August 2017

gram-positive bacteria

0 references

1 reference

1

Sharath S Hegde

1 reference

15 August 2017

5

Robert Skinner

1 reference

15 August 2017

Noe Reyes

2

1 reference

15 August 2017

Tania Wiens

3

1 reference

15 August 2017

Nicole Vanasse

4

1 reference

15 August 2017

Julia McCullough

6

1 reference

15 August 2017

Koné Kaniga

7

1 reference

15 August 2017

John Pace

8

1 reference

15 August 2017

Roger Thomas

9

1 reference

15 August 2017

Jeng-Pyng Shaw

10

1 reference

15 August 2017

Glen Obedencio

11

1 reference

15 August 2017

J Kevin Judice

12

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

Antimicrobial Agents and Chemotherapy

15 August 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

15 August 2017

48

1 reference

15 August 2017

3043-3050

1 reference

15 August 2017

8

1 reference

Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478526

In vitro activity of TD-6424 against Staphylococcus aureus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478526

Staphylococcus aureus resistant to vancomycin--United States, 2002.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478526

Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478526

Animal model pharmacokinetics and pharmacodynamics: a critical review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478526

Linezolid--a review of the first oxazolidinone

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478526

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478526

Development of daptomycin for gram-positive infections

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478526

Vancomycin-resistant enterococcal infections

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478526

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478526

Role of pharmacokinetics in the outcome of infections

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478526

Enhancing effect of serum ultrafiltrate on the activity of cephalosporins against gram-negative bacilli

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478526

Human pharmacodynamics of beta-lactams, aminoglycosides and their combination

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478526

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478526

Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478526

Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478526

National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, issued August 2001

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=478526

Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs

20 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15273119

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A mouse model for simultaneous pharmacokinetic and efficacy studies of antibiotics at sites of infection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15273119

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.48.8.3043-3050.2004

1 reference

15 August 2017

1 reference

15 August 2017

1 reference